As of 2026-04-28, the Relative Valuation of Medexus Pharmaceuticals Inc (MDP.TO) is 0.55 CAD. This relative valuation is based on P/E multiples. With the latest stock price at 3.97 CAD, the upside of Medexus Pharmaceuticals Inc based on Relative Valuation is -86.1%.
The range of the Relative Valuation is (0.09) - 1.77 CAD.
| Range | Selected | |
| Trailing P/E multiples | 10.7x - 13.7x | 13.4x |
| Forward P/E multiples | 13.3x - 21.5x | 14.8x |
| Fair Price | (0.09) - 1.77 | 0.55 |
| Upside | -102.3% - -55.5% | -86.1% |
| Date | P/E |
| 2026-04-24 | -471.44 |
| 2026-04-23 | -473.81 |
| 2026-04-22 | -460.75 |
| 2026-04-21 | -463.12 |
| 2026-04-20 | -472.62 |
| 2026-04-17 | -471.44 |
| 2026-04-16 | -490.44 |
| 2026-04-15 | -478.56 |
| 2026-04-14 | -482.12 |
| 2026-04-13 | -477.37 |
| 2026-04-10 | -467.87 |
| 2026-04-09 | -459.56 |
| 2026-04-08 | -426.31 |
| 2026-04-07 | -420.37 |
| 2026-04-06 | -419.19 |
| 2026-04-02 | -415.62 |
| 2026-04-01 | -389.50 |
| 2026-03-31 | -370.50 |
| 2026-03-30 | -361.00 |
| 2026-03-27 | -365.75 |
| 2026-03-26 | -374.06 |
| 2026-03-25 | -366.94 |
| 2026-03-24 | -377.62 |
| 2026-03-23 | -361.00 |
| 2026-03-20 | -362.19 |
| 2026-03-19 | -372.87 |
| 2026-03-18 | -380.00 |
| 2026-03-17 | -387.12 |
| 2026-03-16 | -371.69 |
| 2026-03-13 | -372.87 |
| 2026-03-12 | -359.81 |
| 2026-03-11 | -368.12 |
| 2026-03-10 | -385.94 |
| 2026-03-09 | -368.12 |
| 2026-03-06 | -368.12 |
| 2026-03-05 | -375.25 |
| 2026-03-04 | -378.81 |
| 2026-03-03 | -374.06 |
| 2026-03-02 | -374.06 |
| 2026-02-27 | -342.00 |
| 2026-02-26 | -342.00 |
| 2026-02-25 | -345.56 |
| 2026-02-24 | -336.06 |
| 2026-02-23 | -337.25 |
| 2026-02-20 | -343.19 |
| 2026-02-19 | -339.62 |
| 2026-02-18 | -338.44 |
| 2026-02-17 | -339.62 |
| 2026-02-13 | -339.62 |
| 2026-02-12 | -325.37 |